Criteria for biocompatibility testing of peritoneal dialysis solutions

[1]  L. Gesualdo,et al.  Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  B. Banas,et al.  Immortalization and characterization of human peritoneal mesothelial cells. , 1997, Kidney international.

[3]  C. Szeto,et al.  Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  C. Kjellstrand,et al.  Sodium ramping in hemodialysis: a study of beneficial and adverse effects. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  D. Struijk,et al.  Longitudinal follow-up of CA125 in peritoneal effluent. , 1997, Kidney international.

[6]  A. Shostak,et al.  Detrimental Effects of Peritoneal Dialysis Solutions upon In Vivo and In Situ Exposed Mesothelium , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  T. Shigematsu,et al.  Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. , 1997, Kidney international.

[8]  S. Granata,et al.  Accuracy of the urinary albumin titrator stick 'Micral-Test' in kidney-disease patients. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  N. Topley.  What is the Ideal Technique for Testing the Biocompatibility of Peritoneal Dialysis Solutions? , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  L. Chung,et al.  Toxicity of L-ascorbic acid to L929 fibroblast cultures: relevance to biocompatibility testing of materials for use in wound management. , 1993, Journal of biomedical materials research.

[11]  M. Flanigan,et al.  Initial Treatment of Dialysis Associated Peritonitis: A Controlled Trial of Vancomycin versus Cefazolin , 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  A. Duwe,et al.  Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro , 1981, Infection and immunity.

[13]  B. Andersen,et al.  Important Variables in Granulocyte Chemiluminescence , 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.